Filter By Industry
Filter By Tag

Newsroom

ScionxBio Press releases

1 - 1 of 1 Press Release

Jul 01, 2026
The rebrand follows a strategic horizontal split; ScionxBio focuses the xRNA modality exclusively on long-acting therapeutics for cardio-metabolic disease under new CEO Dr. Adi Gilboa-Geffen


ScionxBio RSS Feed